Search for: "Generic Pharmaceutical Services, Inc."
Results 481 - 500
of 1,029
Sort by Relevance
|
Sort by Date
5 Jun 2013, 5:29 am
American Medical Systems, Inc., 958 F. [read post]
30 May 2013, 12:58 pm
FlightSafety Int’l, Inc., 277 S.W.3d 696, 700 (Mo. [read post]
28 May 2013, 12:24 am
Department of Health and Human Services’ Office of Inspector General, ISTA, and B+L will enter into a Divestiture Agreement under which ISTA agrees to be excluded for 15 years, effective six months after the date of the settlement. [read post]
27 May 2013, 7:22 pm
See Pharmaceuticals v. [read post]
23 May 2013, 5:00 am
Normally this kind of thing is extremely case specific, and thus not of general interest. [read post]
20 May 2013, 6:56 am
’”); McNeilab, Inc. v. [read post]
16 May 2013, 2:09 pm
Hoffman-La Roche, Inc., 771 F. [read post]
28 Apr 2013, 10:39 pm
The text is due to be transmitted to the WIPO General Assembly in September, 2013. [read post]
12 Apr 2013, 10:01 am
Phoebe Putney Health System, Inc. [read post]
5 Apr 2013, 1:01 pm
Hoffmann-LaRoche Inc., 2013 WL 1191899 (E.D.N.C. [read post]
2 Apr 2013, 10:33 am
George Yu, an experienced patent litigation lawyer at Schiff Hardin LLP on the legality of reverse payment settlements in the pharmaceutical sector- a strategy wherein a patent holder pays a generic pharmaceutical manufacturer to delay or withdraw any challenges to patent validity. [read post]
27 Mar 2013, 10:31 am
Merrill Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
15 Mar 2013, 6:00 am
“Wholesale pharmacies who contract with physicians to provide pharmaceuticals to them on a consignment basis for dispensing to their workers compensation patients, cannot seek payment for the pharmaceuticals directly from the employer/insurer underRebel Distributors Corp., Inc. d/b/a Physician Partner and Pharmacy Partner v. [read post]
15 Mar 2013, 4:41 am
Bartlett, in which the Court will consider whether federal law preempts state law design-defect claims brought against generic pharmaceutical products, here, and in Sebelius v. [read post]
12 Mar 2013, 6:47 am
In his “SCOTUS for law students” feature for this blog, Stephen Wermiel looks at the implied preemption challenge at issue in Mutual Pharmaceutical Co. v. [read post]
3 Mar 2013, 8:42 pm
Subsequently, I wrote about the draft policy proposal issued by Department of Pharmaceuticals (DOP) on price negotiation of patented drugs. [read post]
1 Mar 2013, 2:30 pm
McNeil-PPC, Inc., 2009 WL 1178651, at *3-4 (Pa. [read post]
13 Feb 2013, 10:52 am
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579, 597 (1993). [read post]
11 Feb 2013, 3:12 pm
Stem Cells, Inc. [read post]
11 Feb 2013, 4:37 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
